首页> 外文期刊>Cardiovascular and Interventional Radiology: A Journal of Imaging in Diagnosis and Treatment >Technique-Based Evaluation of Clinical Outcomes and Aortic Remodelling Following TEVAR in Acute and Subacute Type B Aortic Dissection
【24h】

Technique-Based Evaluation of Clinical Outcomes and Aortic Remodelling Following TEVAR in Acute and Subacute Type B Aortic Dissection

机译:基于技术的临床结果评估和急性和亚急性型B主动脉夹层TEVAR后Tevar后的临床结果和主动脉改造

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction To evaluate the clinical outcomes and aortic remodelling rates following thoracic endovascular aortic repair (TEVAR) for acute or subacute type B aortic dissection (TBAD) based on technique. Material and Methods All TEVARs for acute/subacute TBAD between 01/01/2008 and 01/06/2020 were included. TEVARS were grouped by technique (TEVAR only, PETTICOAT and STABILISE). Aortic remodelling was assessed at three aortic levels on follow-up CT. Thirty-day technical/clinical success rates, re-intervention rates and complications were recorded. Results A total of 29 patients were included. The median age was 55 years (31-82). The median duration from initial presentation to TEVAR was 7 days (0-84). Intra-procedural complications included one aortic rupture from balloon moulding in a STABILISE case. Thirty-day mortality, stroke, spinal cord ischaemia and visceral ischaemia were 3% (n = 1), 3% (n = 1), 3% (n = 1) and 3% (n = 1), respectively. (All occurred in acute TBAD.) Overall survival was 50.5 months (18-115). Median follow-up was 31 months (1-115). Six patients (21%) required re-intervention, with a median time of 5 months (5-46) from first TEVAR. Overall complete aortic remodelling rates were: 89% at the proximal descending thoracic aorta, 78% at the distal thoracic aorta and 50% at the infra-renal abdominal aorta. At the infra-renal aorta, the STABILISE group (n = 11) had a higher complete aortic remodelling rate (82%) compared to TEVAR alone (n = 12) (20%). Conclusion Endovascular intervention for acute and subacute TBAD is safe with a high rate of technical success. STABILISE results in higher aortic remodelling at the infra-renal aorta (82%) compared to TEVAR alone (20%) but risks aortic rupture from balloon moulding.
机译:导言:基于技术评估急性或亚急性B型主动脉夹层(TBAD)胸主动脉腔内修复(TEVAR)后的临床结果和主动脉重塑率。材料和方法包括2008年1月1日至2020年6月1日期间急性/亚急性TBAD的所有TEVAR。根据技术(仅限TEVAR、衬裙和稳定)对TEVAR进行分组。在随访的CT上,在三个主动脉水平上评估主动脉重塑。记录30天的技术/临床成功率、再干预率和并发症。结果共纳入29例患者。中位年龄为55岁(31-82岁)。从首次出现到TEVAR的中位持续时间为7天(0-84)。术中并发症包括一例稳定病例的球囊成型导致主动脉破裂。30天死亡率、中风、脊髓缺血和内脏缺血分别为3%(n=1)、3%(n=1)、3%(n=1)和3%(n=1)。(均发生在急性TBAD中。)总生存期为50.5个月(18-115)。中位随访时间为31个月(1-115)。6名患者(21%)需要再次干预,从首次TEVAR开始的中位时间为5个月(5-46)。总的完全主动脉重塑率为:近端降主动脉89%,远端胸主动脉78%,肾下腹主动脉50%。在肾下主动脉,稳定组(n=11)的主动脉完全重塑率(82%)高于单纯TEVAR组(n=12)(20%)。结论血管内介入治疗急性和亚急性TBAD安全,技术成功率高。与单独使用TEVAR(20%)相比,Stabilize可导致肾下主动脉(82%)的主动脉重建更高,但有因球囊成型而导致主动脉破裂的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号